Selected research
Industry Research
Analgesic Creams Industry Research Report 2026
Market perspective
The global Analgesic Creams market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Analgesic Creams is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Analgesic Creams is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Analgesic Creams is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Analgesic Creams include Sanofi, Johnson & Johnson, Novartis, Mylan, Lingrui, Huarun 999, GSK, Topical BioMedics and THE PURE SOURCE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Analgesic Creams market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Analgesic Creams Market by Company
Sanofi
Johnson & Johnson
Novartis
Mylan
Lingrui
Huarun 999
GSK
Topical BioMedics
THE PURE SOURCE
Teikoku Seiyaku
Qizheng
Mercury Healthcare
Hisamitsu
Endo
Actavis
Analgesic Creams Segment by Type
OTC
RX
Analgesic Creams Segment by Application
Muscle Pain
Arthritis Pain
Analgesic Creams Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Analgesic Creams market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Analgesic Creams and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Analgesic Creams.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Analgesic Creams manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Analgesic Creams by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Analgesic Creams in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- OTC
- RX
Applications
- Muscle Pain
- Arthritis Pain
Companies covered
- Sanofi
- Johnson & Johnson
- Novartis
- Mylan
- Lingrui
- Huarun 999
- GSK
- Topical BioMedics
- THE PURE SOURCE
- Teikoku Seiyaku
- Qizheng
- Mercury Healthcare
- Hisamitsu
- Endo
- Actavis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Analgesic Creams Market Size (2021-2032)
- 2.2.2 Global Analgesic Creams Sales (2021-2032)
- 2.2.3 Global Analgesic Creams Market Average Price (2021-2032)
- 2.3 Analgesic Creams by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 OTC
- 2.3.3 RX
- 2.4 Analgesic Creams by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Muscle Pain
- 2.4.3 Arthritis Pain
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Analgesic Creams Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Analgesic Creams Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Analgesic Creams Revenue of Manufacturers (2021-2026)
- 3.4 Global Analgesic Creams Average Price by Manufacturers (2021-2026)
- 3.5 Global Analgesic Creams Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Analgesic Creams, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Analgesic Creams, Product Type & Application
- 3.8 Global Manufacturers of Analgesic Creams, Established Date
- 3.9 Global Analgesic Creams Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Analgesic Creams Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 Johnson & Johnson
- 4.2.1 Johnson & Johnson Company Information
- 4.2.2 Johnson & Johnson Business Overview
- 4.2.3 Johnson & Johnson Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson & Johnson Analgesic Creams Product Portfolio
- 4.2.5 Johnson & Johnson Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Analgesic Creams Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Analgesic Creams Product Portfolio
- 4.4.5 Mylan Recent Developments
- 4.5 Lingrui
- 4.5.1 Lingrui Company Information
- 4.5.2 Lingrui Business Overview
- 4.5.3 Lingrui Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Lingrui Analgesic Creams Product Portfolio
- 4.5.5 Lingrui Recent Developments
- 4.6 Huarun 999
- 4.6.1 Huarun 999 Company Information
- 4.6.2 Huarun 999 Business Overview
- 4.6.3 Huarun 999 Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Huarun 999 Analgesic Creams Product Portfolio
- 4.6.5 Huarun 999 Recent Developments
- 4.7 GSK
- 4.7.1 GSK Company Information
- 4.7.2 GSK Business Overview
- 4.7.3 GSK Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GSK Analgesic Creams Product Portfolio
- 4.7.5 GSK Recent Developments
- 4.8 Topical BioMedics
- 4.8.1 Topical BioMedics Company Information
- 4.8.2 Topical BioMedics Business Overview
- 4.8.3 Topical BioMedics Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Topical BioMedics Analgesic Creams Product Portfolio
- 4.8.5 Topical BioMedics Recent Developments
- 4.9 THE PURE SOURCE
- 4.9.1 THE PURE SOURCE Company Information
- 4.9.2 THE PURE SOURCE Business Overview
- 4.9.3 THE PURE SOURCE Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 THE PURE SOURCE Analgesic Creams Product Portfolio
- 4.9.5 THE PURE SOURCE Recent Developments
- 4.10 Teikoku Seiyaku
- 4.10.1 Teikoku Seiyaku Company Information
- 4.10.2 Teikoku Seiyaku Business Overview
- 4.10.3 Teikoku Seiyaku Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Teikoku Seiyaku Analgesic Creams Product Portfolio
- 4.10.5 Teikoku Seiyaku Recent Developments
- 4.11 Qizheng
- 4.11.1 Qizheng Company Information
- 4.11.2 Qizheng Business Overview
- 4.11.3 Qizheng Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Qizheng Analgesic Creams Product Portfolio
- 4.11.5 Qizheng Recent Developments
- 4.12 Mercury Healthcare
- 4.12.1 Mercury Healthcare Company Information
- 4.12.2 Mercury Healthcare Business Overview
- 4.12.3 Mercury Healthcare Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Mercury Healthcare Analgesic Creams Product Portfolio
- 4.12.5 Mercury Healthcare Recent Developments
- 4.13 Hisamitsu
- 4.13.1 Hisamitsu Company Information
- 4.13.2 Hisamitsu Business Overview
- 4.13.3 Hisamitsu Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Hisamitsu Analgesic Creams Product Portfolio
- 4.13.5 Hisamitsu Recent Developments
- 4.14 Endo
- 4.14.1 Endo Company Information
- 4.14.2 Endo Business Overview
- 4.14.3 Endo Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Endo Analgesic Creams Product Portfolio
- 4.14.5 Endo Recent Developments
- 4.15 Actavis
- 4.15.1 Actavis Company Information
- 4.15.2 Actavis Business Overview
- 4.15.3 Actavis Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Actavis Analgesic Creams Product Portfolio
- 4.15.5 Actavis Recent Developments
5 Global Analgesic Creams Market Scenario by Region
- 5.1 Global Analgesic Creams Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Analgesic Creams Sales by Region: 2021-2032
- 5.2.1 Global Analgesic Creams Sales by Region: 2021-2026
- 5.2.2 Global Analgesic Creams Sales by Region: 2027-2032
- 5.3 Global Analgesic Creams Revenue by Region: 2021-2032
- 5.3.1 Global Analgesic Creams Revenue by Region: 2021-2026
- 5.3.2 Global Analgesic Creams Revenue by Region: 2027-2032
- 5.4 North America Analgesic Creams Market Facts & Figures by Country
- 5.4.1 North America Analgesic Creams Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Analgesic Creams Sales by Country (2021-2032)
- 5.4.3 North America Analgesic Creams Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Analgesic Creams Market Facts & Figures by Country
- 5.5.1 Europe Analgesic Creams Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Analgesic Creams Sales by Country (2021-2032)
- 5.5.3 Europe Analgesic Creams Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Analgesic Creams Market Facts & Figures by Country
- 5.6.1 Asia Pacific Analgesic Creams Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Analgesic Creams Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Analgesic Creams Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Analgesic Creams Market Facts & Figures by Country
- 5.7.1 South America Analgesic Creams Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Analgesic Creams Sales by Country (2021-2032)
- 5.7.3 South America Analgesic Creams Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Analgesic Creams Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Analgesic Creams Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Analgesic Creams Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Analgesic Creams Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Analgesic Creams Sales by Type (2021-2032)
- 6.1.1 Global Analgesic Creams Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Analgesic Creams Sales Market Share by Type (2021-2032)
- 6.2 Global Analgesic Creams Revenue by Type (2021-2032)
- 6.2.1 Global Analgesic Creams Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Analgesic Creams Revenue Market Share by Type (2021-2032)
- 6.3 Global Analgesic Creams Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Analgesic Creams Sales by Application (2021-2032)
- 7.1.1 Global Analgesic Creams Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Analgesic Creams Sales Market Share by Application (2021-2032)
- 7.2 Global Analgesic Creams Revenue by Application (2021-2032)
- 7.2.1 Global Analgesic Creams Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Analgesic Creams Revenue Market Share by Application (2021-2032)
- 7.3 Global Analgesic Creams Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Analgesic Creams Value Chain Analysis
- 8.1.1 Analgesic Creams Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Analgesic Creams Production Mode & Process
- 8.2 Analgesic Creams Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Analgesic Creams Distributors
- 8.2.3 Analgesic Creams Customers
9 Global Analgesic Creams Analyzing Market Dynamics
- 9.1 Analgesic Creams Industry Trends
- 9.2 Analgesic Creams Industry Drivers
- 9.3 Analgesic Creams Industry Opportunities and Challenges
- 9.4 Analgesic Creams Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst